Paper736269
Ultrastructure of developing alveoli. I. The role of the interstitial fibroblast.
Vaccaro C and 1 other. Anat Rec, 1978. Cited by 157 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Ultrastructure of developing alveoli. I. The role of the interstitial fibroblast. Papers, record 736269. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/736269
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibroblasts | Major topic |
| Pulmonary Alveoli | Major topic |
| Age Factors | |
| Air Sacs | |
| Animals | |
| Cell Differentiation | |
| Lung Compliance | |
| Rats |
Source PubMed
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 157 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42103706 | Persistence of alveolar fibroblast-derived ADAMTS4+ cells in a preclinical model of delayed pulmonary fibrosis resolution. | Nat Commun | 2026 | https://conductscience.org/library/papers/42103706 | PubMed |
| 41923294 | Lipid Metabolism and Obesity in Early Life: Drivers of Chronic Lung Disease From Development to Adulthood. | Mol Nutr Food Res | 2026 | https://conductscience.org/library/papers/41923294 | PubMed |
| 41888573 | Ultrastructural and histochemical insights into neotenic and metamorphic axolotl lungs with clues to pulmonary regeneration. | Sci Rep | 2026 | https://conductscience.org/library/papers/41888573 | PubMed |
| 41049730 | Evidence that metformin promotes fibrosis resolution via activating alveolar epithelial stem cells and FGFR2b signaling. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/41049730 | PubMed |
| 39945330 | Unraveling Alveolar Fibroblast and Activated Myofibroblast Heterogeneity and Differentiation Trajectories During Lung Fibrosis Development and Resolution in Young and Old Mice. | Aging Cell | 2025 | https://conductscience.org/library/papers/39945330 | PubMed |
| 39314887 | Pulmonary fibrosis: pathogenesis and therapeutic strategies. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/39314887 | PubMed |
| 37824216 | Functional Pdgfra fibroblast heterogeneity in normal and fibrotic mouse lung. | JCI Insight | 2023 | https://conductscience.org/library/papers/37824216 | PubMed |
| 37463440 | The lung mesenchyme in development, regeneration, and fibrosis. | J Clin Invest | 2023 | https://conductscience.org/library/papers/37463440 | PubMed |
| 37290124 | Hypoxia-Inducible Factor-1α in SM22α-Expressing Cells Modulates Alveolarization. | Am J Respir Cell Mol Biol | 2023 | https://conductscience.org/library/papers/37290124 | PubMed |
| 35129166 | Engineered Lung Tissues Prepared from Decellularized Lung Slices. | J Vis Exp | 2022 | https://conductscience.org/library/papers/35129166 | PubMed |
| 34829987 | Alveologenesis: What Governs Secondary Septa Formation. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34829987 | PubMed |
| 34151224 | Categorization of lung mesenchymal cells in development and fibrosis. | iScience | 2021 | https://conductscience.org/library/papers/34151224 | PubMed |
| 34054525 | Implications for Extracellular Matrix Interactions With Human Lung Basal Stem Cells in Lung Development, Disease, and Airway Modeling. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34054525 | PubMed |
| 33624948 | Resident interstitial lung fibroblasts and their role in alveolar stem cell niche development, homeostasis, injury, and regeneration. | Stem Cells Transl Med | 2021 | https://conductscience.org/library/papers/33624948 | PubMed |
| 33042971 | Use of the Reversible Myogenic to Lipogenic Transdifferentiation Switch for the Design of Pre-clinical Drug Screening in Idiopathic Pulmonary Fibrosis. | Front Bioeng Biotechnol | 2020 | https://conductscience.org/library/papers/33042971 | PubMed |
| 31781555 | Vascular Niche in Lung Alveolar Development, Homeostasis, and Regeneration. | Front Bioeng Biotechnol | 2019 | https://conductscience.org/library/papers/31781555 | PubMed |
| 31166130 | Transitional human alveolar type II epithelial cells suppress extracellular matrix and growth factor gene expression in lung fibroblasts. | Am J Physiol Lung Cell Mol Physiol | 2019 | https://conductscience.org/library/papers/31166130 | PubMed |
| 30770339 | Targeting miR-34a/Pdgfra interactions partially corrects alveologenesis in experimental bronchopulmonary dysplasia. | EMBO Mol Med | 2019 | https://conductscience.org/library/papers/30770339 | PubMed |
| 30769918 | Alveolar-Capillary Membrane-Related Pulmonary Cells as a Target in Endotoxin-Induced Acute Lung Injury. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30769918 | PubMed |
| 30487814 | Role of Fibroblast Growth Factor 10 in Mesenchymal Cell Differentiation During Lung Development and Disease. | Front Genet | 2018 | https://conductscience.org/library/papers/30487814 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/736269
GET https://conductscience.org/api/papers/v1/736269/cited_by?page=2